Neuromusculoskeletal Medicine & OMM · Great Neck, NY
NPI
1982743720
Since 2007
Specialty
Neuromusculoskeletal Medicine & OMM
Code 204D00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1010 Northern Blvd, Ste 136
Great Neck, NY, 11021
Phone (516) 482-4100
Groups this clinician bills Medicare through
Medicare paid, 2024
$212K
4,542 services
Medicare patients, 2024
681
Average age 78
Drug cost, 2024
$8.6M
2,168 prescriptions
Company payments, 2024
$178
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Philip S Ragone was code 99213 (office e&m - established), 526 times for 414 patients. In total Philip S Ragone billed 4,542 services in 33 codes, and Medicare paid $212K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 526 | 414 | $79.19 | $42K |
| 99214 Office E&M - Established | Office | 240 | 212 | $100.57 | $24K |
| 99204 Office E&M - New | Office | 107 | 107 | $139.17 | $15K |
| 95885 Electrical Nerve Conductivity | Office | 38 | 34 | $57.96 | $2,202 |
| 95886 Electrical Nerve Conductivity | Office | 31 | 28 | $89.44 | $2,773 |
| 95911 Electrical Nerve Conductivity | Office | 22 | 22 | $186.75 | $4,109 |
| 95913 Electrical Nerve Conductivity | Office | 11 | 11 | $208.98 | $2,299 |
By year: 2022 $2.1M for 13,443 services; 2023 $715K for 7,121 services; 2024 $212K for 4,542 services.
Medicare prescription drug claims, 2024
In 2024, the drug Philip S Ragone prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 327 prescriptions and refills. In total Philip S Ragone wrote 2,168 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 327 | 824 | 85 | $15K |
| Donepezil Hcl Generic | 233 | 694 | 79 | $3,540 |
| Gabapentin Generic | 98 | 260 | 41 | $2,741 |
| Ultomiris Ravulizumab-Cwvz | 91 | 143 | 14 | $5.7M |
| Prednisone Generic | 88 | 243 | 15 | $824 |
| Escitalopram Oxalate Generic | 61 | 175 | 21 | $1,119 |
| Pregabalin Generic | 56 | 60 | 11 | $1,083 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 53 | 53 | Under 11 | $184K |
| Levetiracetam Generic | 52 | 108 | 11 | $2,063 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 50 | 50 | Under 11 | $406K |
| Memantine Hcl Generic | 50 | 145 | 17 | $1,931 |
| Emgality Pen Galcanezumab-Gnlm | 43 | 43 | Under 11 | $30K |
| Pyridostigmine Bromide Generic | 39 | 96 | 13 | $4,018 |
| Radicava Ors Edaravone | 35 | 35 | Under 11 | $492K |
| Duloxetine Hcl Generic | 32 | 92 | 12 | $954 |
Brand drugs: 452 claims; generic drugs: 1,704 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Philip S Ragone $178 ($178 in general payments such as food, travel and fees) from 2 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $102.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.